{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T04:54:33Z","timestamp":1667710473190},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.1248\/yakushi.22-00138","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T22:21:37Z","timestamp":1667254897000},"page":"1267-1276","source":"Crossref","is-referenced-by-count":0,"title":["Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock"],"prefix":"10.1248","volume":"142","author":[{"given":"Toshihisa","family":"Onoda","sequence":"first","affiliation":[{"name":"Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Izawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toho University Sakura Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Urano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toho University Sakura Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toho University Sakura Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Toho University Sakura Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Ibanez B., James S., Agewall S., Antunes M. J., Bucciarelli-Ducci C., Bueno H., Caforio A. L. P., Crea F., Goudevenos J. A., Halvorsen S., Hindricks G., Kastrati A., Lenzen M. J., Prescott E., Roffi M., Valgimigli M., Varenhorst C., Vranckx P., Widimsk\u00fd P., ESC Scientific Document Group, <i>Eur. Heart J.<\/i>, <b>39<\/b>, 119-177 (2018)."},{"key":"2","unstructured":"2) Chioncel O., Parissis J., Mebazaa A., <i>et al.<\/i>, <i>Eur. J. Heart Fail.<\/i>, <b>22<\/b>, 1315-1341 (2020)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shah M., Patnaik S., Patel B., Ram P., Garg L., Agarwal M., Agrawal S., Arora S., Patel N., Wald J., Jorde U. P., <i>Clin. Res. Cardiol.<\/i>, <b>107<\/b>, 287-303 (2018).","DOI":"10.1007\/s00392-017-1182-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Chioncel O., Mebazaa A., Harjola V. P., Coats A. J., Piepoli M. F., Crespo-Leiro M. G., Laroche C., Seferovic P. M., Anker S. D., Ferrari R., Ruschitzka F., Lopez-Fernandez S., Miani D., Filippatos G., Maggioni A. P., ESC Heart Failure Long-Term Registry Investigators, <i>Eur. J. Heart Fail.<\/i>, <b>19<\/b>, 1242-1254 (2017).","DOI":"10.1002\/ejhf.890"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chioncel O., Collins S. P., Ambrosy A. P., Pang P. S., Radu R. I., Antohi E. L., Masip J., Butler J., Iliescu V. A., <i>Am. J. Ther.<\/i>, <b>26<\/b>, e234-e247 (2019).","DOI":"10.1097\/MJT.0000000000000920"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Levy B., Perez P., Perny J., Thivilier C., Gerard A., <i>Crit. Care Med.<\/i>, <b>39<\/b>, 450-455 (2011).","DOI":"10.1097\/CCM.0b013e3181ffe0eb"},{"key":"7","unstructured":"7) The Japanese Circulation Society, The Japanese Heart Failure Society. \u201cGuidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure 2017.\u201d: \u3008https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2017\/06\/JCS2017_tsutsui_h.pdf\u3009, cited 13 June, 2022."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Vallabhajosyula S., Patlolla S. H., Verghese D., Ya&apos;Qoub L., Kumar V., Subramaniam A. V., Cheungpasitporn W., Sundaragiri P. R., Noseworthy P. A., Mulpuru S. K., Bell M. R., Gersh B. J., Deshmukh A. J., <i>Am. J. Cardiol.<\/i>, <b>125<\/b>, 1774-1781 (2020).","DOI":"10.1016\/j.amjcard.2020.03.015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) DeMonaco H. J., <i>Crit. Care Med.<\/i>, <b>18<\/b>, 896 (1990).","DOI":"10.1097\/00003246-199008000-00025"},{"key":"10","unstructured":"10) Fuji Pharma Co., Ltd., Dobutamine Interview form, 12th ed., February 2019: \u3008https:\/\/www.fuji-pharma.jp\/docs\/291\/interview_291.pdf\u3009, cited 14 June, 2022."},{"key":"11","unstructured":"11) Fuji Pharma Co., Ltd., Milrinone Interview form, 2nd ed., January 2010: \u3008https:\/\/www.fuji-pharma.jp\/docs\/200\/interview_200.pdf\u3009, cited 13 June, 2022."},{"key":"12","unstructured":"12) Ono Pharmaceutical Co., Ltd., Onoact result of mixing test, October 2020: \u3008https:\/\/www.ononavi1717.jp\/products\/onoact\/documents\u3009, cited 14 June, 2022."},{"key":"13","unstructured":"13) Pharmaceuticals and Medical Devices Agency. \u201cList of approved products for new drugs.\u201d: \u3008https:\/\/www.pmda.go.jp\/review-services\/drug-reviews\/review-information\/p-drugs\/0010.html\u3009, cited 17 June, 2022."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Grillo J. A., Gonzalez E. R., Ramaiya A., Karnes H. T., Wells B., <i>Crit. Care Med.<\/i>, <b>23<\/b>, 1061-1066 (1995).","DOI":"10.1097\/00003246-199506000-00011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wei P., Gangapurwala G., Pretzel D., Leiske M. N., Wang L., Hoeppener S., Schubert S., Brendel J. C., Schubert U. S., <i>Biomacromolecules<\/i>, <b>20<\/b>, 130-140 (2019).","DOI":"10.1021\/acs.biomac.8b01228"},{"key":"16","unstructured":"16) Ono Pharmaceutical Co., Ltd., Onoact Interview form, 12th ed., June 2020: \u3008https:\/\/www.ononavi1717.jp\/system\/files\/assets\/q\/a\/area\/cardiology\/onoact\/drug-info\/10030007\/if\/OA_IF_1.pdf\u3009, cited 13 June, 2022."},{"key":"17","unstructured":"17) Alfresa Pharma Corporation, Nor-adrenalin Interview form, March 2019: \u3008https:\/\/www.alfresa-pharma.co.jp\/product\/attach\/PRODUCT_ID\/554\/FILE_ID\/INT-ERVIEW_FORM\/554_INTERVIEW_FORM\u3009, cited 14 June, 2022."},{"key":"18","unstructured":"18) Myotoku M., <i>Yakkyoku<\/i>, <b>70<\/b>, 1734-1742 (2019)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Imamura T., Kinugawa K., <i>ESC Heart Fail.<\/i>, <b>7<\/b>, 2208-2213 (2020).","DOI":"10.1002\/ehf2.12879"}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/142\/11\/142_22-00138\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T03:26:28Z","timestamp":1667618788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/142\/11\/142_22-00138\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.22-00138","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"22-00138"}}